adenosine diphosphate has been researched along with Emergencies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beynon, C; Jakobs, M; Jung, C; Sakowitz, OW; Scherer, M; Unterberg, AW | 1 |
Collen, D; Coller, BS; Finkelstein, D; Gimple, LW; Gold, HK; Johns, JA; Leinbach, RC; Werner, W; Yasuda, T; Ziskind, AA | 1 |
2 other study(ies) available for adenosine diphosphate and Emergencies
Article | Year |
---|---|
Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Clopidogrel; Embolization, Therapeutic; Emergencies; Emergency Medical Services; Female; Hemostatic Techniques; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Transfusion; Point-of-Care Systems; Ticlopidine | 2013 |
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Adenosine Diphosphate; Aspirin; Bleeding Time; Emergencies; Fibrin Fibrinogen Degradation Products; Hematocrit; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 1989 |